Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test
On Apr. 2, 2025, Revvity announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure…
On Apr. 2, 2025, Revvity announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure…
On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…
On Mar. 28, 2025, the Texas Department of State Health Services (DSHS) reported updated information about an outbreak…
On Mar. 28, 2025, Visby Medical™ announced that the U.S. Food and Drug Administration (FDA) has granted De…
On Mar. 28, 2025, the U.S. Food and Drug Administration (FDA) announced approval of Alnylam Pharmaceuticals Qfitlia™ (fitusiran),…
On Mar. 27, 2025, Utah become the first state to ban fluoride in public drinking water, over opposition…
On Mar. 27, 2025, The Hospital for Sick Children (SickKids) announced it is harnessing the transformative potential of…
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Mar. 26, 2025, researchers announced they have discovered a new antibiotic molecule that targets a broad range…
On Mar. 26, 2025, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the…
On Mar. 25. 2025, the UK Health Security Agency (UKHSA) published its view on the pathogen families that…
On Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
On Mar. 25, 2025, research from the American College of Cardiology reported that tiny fragments of plastic have…
On Mar. 25, 2025, GSK announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin)…
On Mar. 24, 2025, LifeScienceHistory.com published the cartoon “Milestones in Fluoride” illustrating the facts behind the naturally occurring…
On Mar. 24, 2025, Hideyuki Okano, a stem-cell scientist at Keio University in Tokyo, and his colleagues announced…
On Mar. 24, 2025, As bird flu ravages poultry farms across the country – including in South Dakota…
On Mar. 24, 2025, Tuberculosis (TB) infections among children in the European region rose 10% in 2023, indicating…
On Mar. 23, 2025, 23andMe announced that it has initiated voluntary Chapter 11 proceedings in the U.S. Bankruptcy…
On Mar. 21, 2025, the Texas Department of State Health Services (DSHS) reported updated information about an outbreak…
On Mar. 20, 2025, Alnylam Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of the supplemental…
On Mar. 20, 2025, the U.S. Department of Agriculture (USDA) in consultation with the U.S. Department of Health…
On Mar. 20, 2025, Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan, a major step towards finalizing a…
On Mar. 18, 2025, an interdisciplinary group of researchers from Rice University announced they have created a new…
On Mar. 17, 2025, The Mississippi Board of Animal Health (MBAH) has been notified by the U.S.Department of…
On Mar. 14, 2025, Sanofi announced the immediate adoption of influenza strains selected by the U.S. Food and…
On Mar. 14, 2025, the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) announced an…
On Mar. 14, 2025, the Texas Department of State Health Services (DSHS) reported updated information about an outbreak…
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
On Mar. 14, 2025, a survey by the Annenberg Public Policy Center (APPC) reported that although the Food…